Tags
You are here: Home
Millipore
Dominique Baly Appointed to Sartorius Top Management Team
Former Millipore executive Dominique Baly, has assumed cross-divisional management of marketing, sales and service for the Sartorius laboratory business as president of Sartorius group Laboratory Business. In this newly created position, he reports to the CEO and is a member of the group executive committee. Sartorius Group highest-level management team is now composed of six individuals, including the executives of both Sartorius AG and the subgroup Sartorius Stedim Biotech. more
Uta Kemmerich-Keil: Merck KGaA to Refrain From Big Deals For Now
German drugmaker Merck KGaA will take a breather from pursuing larger takeover deals as it integrates its latest acquisition Millipore, a company executive said on Tuesday. "You will not see us involved in transactions of (Millipore's) size in the short term," the company's head of corporate finance, Uta Kemmerich-Keil, said at an event, adding that management's focus was on integrating the laboratory equipment supplier. Merck agreed to buy U.S. biotech tool maker Millipore for $6 billion in cash in February to diversify away from its pharmaceuticals business. more03.08.2010Merck KGaA Profit After Tax Jumps 70% to €187 Million in Q2 2010
All four divisions of the Merck Group, especially the chemicals divisions, recorded increases in Q2 2010 revenues, leading to a record €2,208 million in total revenues for the group. This was a 16% increase compared to the year-ago amount of €1,910 million. In the first half of 2010, total revenues rose 14% to €4,307 million. With revenues increasing at a faster rate than cost of sales, the gross margin rose 22% in the second quarter to €1,691 million. more08.07.2010Merck Gets EU Nod for U.S. Biotech Millipore Buy
German drugmaker Merck secured EU regulatory approval on Wednesday for its takeover of U.S. biotech tool maker Millipore, marking a diversification away from the pharmaceuticals business. more
Millipore Introduces Premixed Western Blot Detection Reagent
Millipore Corporation, a leading provider of technologies, tools, and services for the global life science industry, has announced the introduction of a new line of premixed Western blot detection reagents. Luminata horseradish peroxidase (HRP) detection reagents offer high sensitivity and convenient chemiluminescent detection.more
'A Merger For Growth'
Global pharmaceutical and chemical company Merck KGaA headquartered in Darmstadt, Germany, will acquire Millipore Corporation, a leading Life Science company based in Billerica, U.S., for approximately €5.3 billion to create a €2.1 billion world-class partner for the life science sector. Right after the announcement on Feb. 28, G.I.T. had the chance to talk to Dr. Karl-Ludwig Kley, Chairman of the Executive Board of Merck and Dr. more02.03.2010Is Merck KGaA's $6 Billion Bid for Millipore Too Costly?
Germany's family-controlled Merck KGaA agreed to buy U.S. biotech tool maker Millipore for $6 billion to diversify away from its embattled drugs business. While analysts said the deal made strategic sense, they were also concerned Merck may be paying too much for the maker of filters and purifiers for laboratory water and other materials used in making biotechnology drugs. more
Update: Merck KGaA Buys Millipore to Stabilize Business
Merck KGaA's agreed $6 billion cash purchase of U.S. biotech tool maker Millipore buoyed the German drugmaker's share on Monday as it diversified away from its embattled pharmaceuticals business. Merck, which makes the multiple sclerosis drug Rebif and owns the rights to cancer drug Erbitux in Europe, agreed on Sunday to buy Millipore in a deal that boosts its lab equipment business. more
Germany's Merck to Buy Millipore in $6 Billion Deal
Germany's Merck KGaA on Sunday said it agreed to buy U.S. biotech tool maker Millipore for around $6 billion in cash, as the company looks to build its lab equipment business. Merck, the world's largest maker of chemicals for flat-panel displays, said late on Sunday it agreed to acquire Millipore for $107 per share in cash, valuing the deal at around $7.2 billion including net debt. more24.02.2010Millipore Says Evaluating ‘Strategic Alternatives’
Millipore, which is under a $6 billion takeover offer from U.S. laboratory equipment maker Thermo FisherScientific, said it hired Goldman Sachs as an advisor in evaluating "strategic alternatives." A source familiar with the situation told Reuters on Monday Thermo Fisher Scientific has offered to buy Millipore. Millipore said it not has set a definitive timetable for completion of its evaluation. more
- Legal
- Help
- Participate
- Related Publications